id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0583-0001,FDA,FDA-2011-N-0583,Orphan Drug Regulations,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2011-10-19T04:00:00Z,2011,10,2011-10-19T04:00:00Z,2012-01-18T04:59:59Z,2011-10-19T20:37:45Z,2011-27037,0,0,0900006480f55c83